Variant report
Variant | esv1835799 |
---|---|
Chromosome Location | chr9:43314125-43354573 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:78)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr9:43341402-43341565 | A549 | lung: | n/a | n/a |
2 | CTCF | chr9:43341397-43341590 | GM19239 | blood: | n/a | n/a |
3 | CTCF | chr9:43341490-43341501 | GM20000 | blood: | n/a | n/a |
4 | CTCF | chr9:43341422-43341541 | GM19240 | blood: | n/a | n/a |
5 | CTCF | chr9:43321004-43321125 | MCF-7 | breast: | n/a | n/a |
6 | CTCF | chr9:43341412-43341569 | GM12892 | blood: | n/a | n/a |
7 | CTCF | chr9:43335241-43335681 | A549 | lung: | n/a | n/a |
8 | CTCF | chr9:43341244-43341768 | A549 | lung: | n/a | n/a |
9 | CTCF | chr9:43335382-43335606 | K562 | blood: | n/a | n/a |
10 | CTCF | chr9:43335399-43335642 | A549 | lung: | n/a | n/a |
11 | CTCF | chr9:43341476-43341556 | GM13977 | blood: | n/a | n/a |
12 | CTCF | chr9:43323336-43323368 | Lung_OC | lung: | n/a | n/a |
13 | CTCF | chr9:43320972-43321053 | GM10248 | blood: | n/a | n/a |
14 | CTCF | chr9:43341390-43341591 | HepG2 | liver: | n/a | n/a |
15 | CTCF | chr9:43335460-43335543 | HepG2 | liver: | n/a | n/a |
16 | CTCF | chr9:43341372-43341420 | GM13977 | blood: | n/a | n/a |
17 | CTCF | chr9:43341363-43341597 | K562 | blood: | n/a | n/a |
18 | CTCF | chr9:43320815-43321216 | A549 | lung: | n/a | n/a |
19 | CTCF | chr9:43321016-43321108 | GM10266 | blood: | n/a | n/a |
20 | CTCF | chr9:43335287-43335666 | A549 | lung: | n/a | n/a |
21 | CTCF | chr9:43321036-43321129 | Medullo | brain: | n/a | n/a |
22 | CTCF | chr9:43341292-43341625 | A549 | lung: | n/a | n/a |
23 | CTCF | chr9:43341411-43341567 | Pancreas_OC | pancreas: | n/a | n/a |
24 | CTCF | chr9:43341364-43341622 | GM10248 | blood: | n/a | n/a |
25 | CTCF | chr9:43341776-43341857 | Spleen_OC | spleen: | n/a | n/a |
26 | CTCF | chr9:43320771-43321249 | A549 | lung: | n/a | n/a |
27 | CTCF | chr9:43341408-43341612 | LNCaP | prostate: | n/a | n/a |
28 | CTCF | chr9:43341397-43341592 | Gliobla | brain: | n/a | n/a |
29 | CTCF | chr9:43341408-43341577 | Hela-S3 | cervix: | n/a | n/a |
30 | CTCF | chr9:43321020-43321053 | GM13977 | blood: | n/a | n/a |
31 | CTCF | chr9:43341264-43341654 | A549 | lung: | n/a | n/a |
32 | CTCF | chr9:43341261-43341631 | A549 | lung: | n/a | n/a |
33 | CTCF | chr9:43341987-43342057 | GM10266 | blood: | n/a | n/a |
34 | CTCF | chr9:43350560-43350577 | Lung_OC | lung: | n/a | n/a |
35 | CTCF | chr9:43341326-43341673 | K562 | blood: | n/a | n/a |
36 | CTCF | chr9:43321132-43321147 | GM13976 | blood: | n/a | n/a |
37 | CTCF | chr9:43341355-43341619 | Medullo | brain: | n/a | n/a |
38 | CTCF | chr9:43321067-43321088 | GM19239 | blood: | n/a | n/a |
39 | CTCF | chr9:43341435-43341538 | GM19238 | blood: | n/a | n/a |
40 | CTCF | chr9:43319743-43319832 | GM10266 | blood: | n/a | n/a |
41 | CTCF | chr9:43341408-43341568 | ProgFib | skin: | n/a | n/a |
42 | CTCF | chr9:43341386-43341606 | HUVEC | blood vessel: | n/a | n/a |
43 | CTCF | chr9:43341383-43341644 | Kidney_OC | kidney: | n/a | n/a |
44 | CTCF | chr9:43321001-43321114 | GM12878 | blood: | n/a | n/a |
45 | CTCF | chr9:43321075-43321079 | LNCaP | prostate: | n/a | n/a |
46 | CTCF | chr9:43341394-43341583 | NHEK | skin: | n/a | n/a |
47 | CTCF | chr9:43341417-43341534 | Fibrobl | skin: | n/a | n/a |
48 | CTCF | chr9:43341343-43341666 | Spleen_OC | spleen: | n/a | n/a |
49 | CTCF | chr9:43341391-43341582 | GM12878 | blood: | n/a | n/a |
50 | CTCF | chr9:43341327-43341614 | K562 | blood: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ANKRD20A3-11 | chr9:43319264-43319576 | NONHSAT131357 |
2 | lnc-ANKRD20A3-11 | chr9:43318619-43318952 | NONHSAT131357 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000224828 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs28552539 | chr9:43314125-43314126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs587662135 | chr9:43314134-43314135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs587742134 | chr9:43314160-43314161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs587621107 | chr9:43314163-43314164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373415998 | chr9:43314184-43314185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs587730168 | chr9:43314198-43314199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs73648327 | chr9:43314201-43314202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs28668662 | chr9:43314207-43314208 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs587728946 | chr9:43314220-43314221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs587616891 | chr9:43314221-43314222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs113790172 | chr9:43314251-43314252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs386734653 | chr9:43314263-43314264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs587683458 | chr9:43314283-43314284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs587743023 | chr9:43314294-43314295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs28464966 | chr9:43314341-43314342 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs587618287 | chr9:43314348-43314349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs373266743 | chr9:43314349-43314350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191964235 | chr9:43314350-43314351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs28657516 | chr9:43314352-43314353 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs587683241 | chr9:43314368-43314369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs587767028 | chr9:43314371-43314372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148585672 | chr9:43314373-43314374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs587747903 | chr9:43314374-43314375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs587619318 | chr9:43314390-43314391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs587677200 | chr9:43314406-43314407 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs587716854 | chr9:43314414-43314415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115069136 | chr9:43314431-43314432 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371279712 | chr9:43314434-43314435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371583730 | chr9:43314448-43314449 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185585686 | chr9:43314456-43314457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs587722180 | chr9:43314475-43314476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs373065244 | chr9:43314489-43314490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs28561522 | chr9:43314508-43314509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
34 | rs201613679 | chr9:43314510-43314511 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs587618042 | chr9:43314523-43314524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs28420826 | chr9:43314525-43314526 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs587695204 | chr9:43314533-43314534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188924895 | chr9:43314547-43314548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs587623066 | chr9:43314554-43314555 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs35360257 | chr9:43314556-43314557 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs587686405 | chr9:43314563-43314564 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs587765097 | chr9:43314603-43314604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs587666381 | chr9:43314620-43314621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192409788 | chr9:43314622-43314623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184595340 | chr9:43314649-43314650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs28454724 | chr9:43314656-43314657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373648730 | chr9:43314660-43314661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs149767052 | chr9:43314685-43314686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs587772999 | chr9:43314712-43314713 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs587657934 | chr9:43314717-43314718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 22183965 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Oral cancer | 21386901 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 20409316 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Schizophrenia | 21346763 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 21990379 | CNVD |
Astrocytoma | 22246337 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:43314000-43314200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr9:43314000-43314800 | Enhancers | Fetal Brain Male | brain |
3 | chr9:43314400-43315400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr9:43314800-43315800 | Weak transcription | Fetal Brain Male | brain |
5 | chr9:43315400-43316000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
6 | chr9:43315400-43316000 | Enhancers | NHEK | skin |
7 | chr9:43316000-43316200 | Enhancers | Fetal Brain Male | brain |